FDA Releases Guidance for Fibrin Sealant Manufacturers on Efficacy Studies

Summary

The Food and Drug Administration (FDA) has made available a guidance document outlining the requirements for efficacy studies to support the marketing of commercially-produced fibrin sealant products, with a focus on hemostasis effectiveness as the primary endpoint.